<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=13875"><dc:title>Selective response to omalizumab in a patient with concomitant ncMCAS and POTS : what does it teach us about the underlying disease?</dc:title><dc:creator>Kačar,	Mark	(Avtor)
	</dc:creator><dc:creator>Denman,	S	(Avtor)
	</dc:creator><dc:creator>Savic,	Sinisa	(Avtor)
	</dc:creator><dc:subject>mastocytosis</dc:subject><dc:subject>postural orthostatic tachycardia syndrome</dc:subject><dc:subject>omalizumab</dc:subject><dc:subject>nonclonal mast cell activation syndrome</dc:subject><dc:publisher>ESMON Publicidad</dc:publisher><dc:date>2018</dc:date><dc:date>2021-04-08 14:56:14</dc:date><dc:type>Neznano</dc:type><dc:identifier>13875</dc:identifier><dc:language>sl</dc:language><dc:rights>© 2018 Esmon Publicidad</dc:rights></rdf:Description></rdf:RDF>